Evaluation of Peri-Operative Outcomes after Prostatic Urethral Lift with Emphasis on Urodynamic Changes, Symptom Improvement and Sexual Function
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Lokeshwar, S.D.; Harper, B.T.; Webb, E.; Jordan, A.; Dykes, T.A.; Neal, D.E., Jr.; Terris, M.K.; Klaassen, Z. Epidemiology and treatment modalities for the management of benign prostatic hyperplasia. Transl. Androl. Urol. 2019, 8, 529–539. [Google Scholar] [CrossRef] [PubMed]
- Gravas, S.; Malde, S.; Cornu, J.-N.; Gacci, M.; Gratzke, C.; Herrmann, T.R.W.; Karavitakis, M.; Mamoulakis, C.; Rieken, M.; Sakalis, V.I.; et al. From BPH to male LUTS: A 20-year journey of the EAU guidelines. Prostate Cancer Prostatic Dis. 2023, 27, 48–53. [Google Scholar] [CrossRef]
- Abrams, P.; Cardozo, L.; Fall, M.; Griffiths, D.; Rosier, P.; Ulmsten, U.; Van Kerrebroeck, P.; Victor, A.; Wein, A. The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Urology 2003, 61, 37–49. [Google Scholar] [CrossRef] [PubMed]
- De Nunzio, C.; Franco, A.; Lombardo, R.; Baldassarri, V.; Borghesi, A.; Marzi, V.L.; Trucchi, A.; Agrò, E.F.; Tubaro, A.; The Publications Committee of Italian Society of Urodynamics (SIUD). Phamacological treatment of persistant lower urinary tract symptoms after a transurethral resection of the prostate is predictive of a new surgical treatment: 10 years follow-up study. Neurourol. Urodyn. 2021, 40, 722–727. [Google Scholar] [CrossRef]
- Sahakyan, Y.; Erman, A.; Bhojani, N.; Chughtai, B.; Zorn, K.C.; Sander, B.; Elterman, D.S. Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: A cost-effectiveness study. Prostate Cancer Prostatic Dis. 2023, 26, 113–118. [Google Scholar] [CrossRef]
- Woo, H.H.; Chin, P.T.; McNicholas, T.A.; Gill, H.S.; Plante, M.K.; Bruskewitz, R.C.; Roehrborn, C.G. Safety and feasibility of the prostatic urethral lift: A novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int. 2011, 108, 82–88. [Google Scholar] [CrossRef]
- Sønksen, J.; Barber, N.J.; Speakman, M.J.; Berges, R.; Wetterauer, U.; Greene, D.; Sievert, K.-D.; Chapple, C.R.; Montorsi, F.; Patterson, J.M.; et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur. Urol. 2015, 68, 643–652. [Google Scholar] [CrossRef]
- Perera, M.; Roberts, M.J.; Doi, S.A.R.; Bolton, D. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: A systematic review and meta-analysis. Eur. Urol. 2015, 67, 704–713. [Google Scholar] [CrossRef]
- Tanneru, K.; Gautam, S.; Norez, D.; Kumar, J.; Alam, M.U.; Koocheckpour, S.; Balaji, K.C.; Joseph, C. Meta-analysis and systematic review of intermediate-term follow-up of prostatic urethral lift for benign prostatic hyperplasia. Int. Urol. Nephrol. 2020, 52, 999–1008. [Google Scholar] [CrossRef] [PubMed]
- de Jongh, R.; van Koeveringe, G.A.; van Kerrebroeck, P.E.V.; Markerink-van Ittersum, M.; de Vente, J.; Gillespie, J.I. Damage to the bladder neck alters autonomous activity and its sensitivity to cholinergic agonists. BJU Int. 2007, 100, 919–929. [Google Scholar] [CrossRef]
- Roehrborn, C.G. Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: Achievements and limitations. Rev. Urol. 2008, 10, 14–25. [Google Scholar] [PubMed]
- Milonas, D.; Verikaite, J.; Jievaltas, M. The effect of complete transurethral resection of the prostate on symptoms, quality of life, and voiding function improvement. Cent. Eur. J. Urol. 2015, 68, 169–174. [Google Scholar] [CrossRef] [PubMed]
- Jung, J.H.; Reddy, B.; McCutcheon, K.A.; Borofsky, M.; Narayan, V.; Kim, M.H.; Dahm, P. Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. Cochrane Database Syst. Rev. 2019, 5, CD012832. [Google Scholar] [CrossRef]
- Kaplan, S.A. Re: Meta-Analysis and Systematic Review of Intermediate-Term Follow-Up of Prostatic Urethral Lift for Benign Prostatic Hyperplasia. J. Urol. 2020, 204, 593. [Google Scholar] [CrossRef]
- Roehrborn, C.G.; Barkin, J.; Gange, S.N.; Shore, N.D.; Giddens, J.L.; Bolton, D.M.; Cowan, B.E.; Cantwell, A.L.; McVary, K.T.; Te, A.E.; et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can. J. Urol. 2017, 24, 8802–8813. [Google Scholar]
- Mogensen, K.; Jacobsen, J.D. The load on family and primary healthcare in the first six weeks after transurethral resection of the prostate. Scand. J. Urol. Nephrol. 2008, 42, 132–136. [Google Scholar] [CrossRef] [PubMed]
- Frieben, R.W.; Lin, H.-C.; Hinh, P.P.; Berardinelli, F.; Canfield, S.E.; Wang, R. The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: A systematic review. Asian J. Androl. 2010, 12, 500–508. [Google Scholar] [CrossRef]
- Dean, N.S.; Assmus, M.A.; Lee, M.S.; Guo, J.N.; Krambeck, A.E. Benign prostatic hyperplasia surgical re-treatment after prostatic urethral lift A narrative review. Can. Urol. Assoc. J. 2023, 17, 353–359. [Google Scholar] [CrossRef]
- Muller, B.G.; Martens, F.M.J.; Heesakkers, J.P.F.A.; d’Ancona, F.C.H. Urodynamic Effects of Prostatic Urethral Lift Procedure for Male Voiding Lower Urinary Tract Symptoms. J. Endourol. 2021, 35, 1813–1817. [Google Scholar] [CrossRef]
- Gacci, M.; Makrides, P.; Spatafora, P. Impact of medical treatment on storage and voiding LUTS, nocturia, and quality of life in men at risk for progression. Prostate Cancer Prostatic Dis. 2024, 27, 170–171. [Google Scholar] [CrossRef]
- Kaplan, S.; Kaufman, R.P.; Mueller, T.; Elterman, D.; Chughtai, B.; Rukstalis, D.; Woo, H.; Roehrborn, C. Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: A US healthcare claims and utilization study. Prostate Cancer Prostatic Dis. 2023, 27, 485–491. [Google Scholar] [CrossRef] [PubMed]
- Destefanis, P.; Sibona, M.; Vitiello, F.; Vercelli, E.; Micai, L.; Montefusco, G.; Mangione, C.; Bracco, F.; Colucci, F.; De Nunzio, C.; et al. Trans—Perineal laser ablation of the prostate in high surgical risk patients affected by severe lower urinary tract symptoms related to benign prostatic obstruction. Prostate Cancer Prostatic Dis. 2023. [Google Scholar] [CrossRef] [PubMed]
- Zhu, M.; Babar, M.; Hawks-Ladds, N.; Tawfik, M.-M.; Loloi, J.; Labagnara, K.; Sayed, R.; Tang, K.; Salami, A.; Singh, S.; et al. Real-world four-year functional and surgical outcomes of Rezum therapy in younger versus elderly men. Prostate Cancer Prostatic Dis. 2024, 27, 109–115. [Google Scholar] [CrossRef] [PubMed]
- Sibona, M.; Destefanis, P.; Vercelli, E.; Secco, S.; Gontero, P.; Cindolo, L. Ejaculation physiology and dysfunction after BPH surgery: The role of the new MISTs. Prostate Cancer Prostatic Dis. 2023, 26, 475–482. [Google Scholar] [CrossRef]
- Nguyen, D.-D.; Li, T.; Ferreira, R.; Berjaoui, M.B.; Nguyen, A.-L.V.; Chughtai, B.; Zorn, K.C.; Bhojani, N.; Elterman, D. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation. Prostate Cancer Prostatic Dis. 2024, 27, 22–28. [Google Scholar] [CrossRef]
- Huang, J.; Chan, C.-K.; Yee, S.; Deng, Y.; Bai, Y.; Chan, S.C.; Tin, M.S.; Liu, X.; Lok, V.; Zhang, L.; et al. Global burden and temporal trends of lower urinary tract symptoms: A systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2023, 26, 421–428. [Google Scholar] [CrossRef]
- Woo, H.H.; Huang, C.-P.; Huang, W.J.; Chang, Y.-H.; Lien, C.-S.; Chkhotua, A.; Elterman, D.S. The EXPANDER-1 trial: Introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). Prostate Cancer Prostatic Dis. 2022, 25, 576–582. [Google Scholar] [CrossRef]
- Chin, P.T.; Bolton, D.M.; Jack, G.; Rashid, P.; Thavaseelan, J.; Yu, R.J.; Roehrborn, C.G.; Woo, H.H. Prostatic urethral lift: Two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 2012, 79, 5. [Google Scholar] [CrossRef]
- McNicholas, T.A.; Woo, H.H.; Chin, P.T.; Bolton, D.; Arjona, M.F.; Sievert, K.-D.; Schoenthaler, M.; Wetterauer, U.; Vrijhof, E.J.; Gange, S.; et al. Minimally invasive prostatic urethral lift: Surgical technique and multinational experience. Eur. Urol. 2013, 64, 292. [Google Scholar] [CrossRef]
- Roehrborn, C.G.; Gange, S.N.; Shore, N.D.; Giddens, J.L.; Bolton, D.M.; Cowan, B.E.; Brown, B.T.; McVary, K.T.; Te, A.E.; Gholami, S.S.; et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: The L.I.F.T. Study. J. Urol. 2013, 190, 2161. [Google Scholar] [CrossRef]
- Woo, H.H.; Bolton, D.M.; Laborde, E.; Jack, G.; Chin, P.T.; Rashid, P.; Thavaseelan, J.; McVary, K.T. Preservation of sexual function with the prostatic urethral lift: A novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J. Sex. Med. 2012, 9, 568. [Google Scholar] [CrossRef] [PubMed]
- Porreca, A.; Colicchia, M.; Tafuri, A.; D’agostino, D.; Busetto, G.M.; Crestani, A.; Odorizzi, K.; Amigoni, N.; Rizzetto, R.; Gozzo, A.; et al. Perioperative outcomes of Holmium laser enucleation of the prostate: A systematic review. Urol. Int. 2022, 106, 979–991. [Google Scholar] [CrossRef] [PubMed]
- Grosso, A.A.; Amparore, D.; Di Maida, F.; de Cillis, S.; Cocci, A.; Di Dio, M.; Russo, G.I.; Cimino, S.; Quarà, A.; Salvi, M.; et al. Comparison of perioperative and short-terms outcomes of en-bloc Holmium laser enucleation of the prostate (HoLEP) and robot-assisted simple prostatectomy: A propensity-score matching analysis. Prostate Cancer Prostatic Dis. 2023, 27, 478–484. [Google Scholar] [CrossRef]
- Porreca, A.; Schiavina, R.; Romagnoli, D.; Corsi, P.; Salvaggio, A.; D’Agostino, D.; Ferro, M.; Busetto, G.M.; Falabella, R.; Crestani, A. T-L technique for HoLEP: Perioperative outcomes of a large single-centre series. Cent. Eur. J. Urol. 2021, 74, 366–371. [Google Scholar]
- Cash, H.; Wendler, J.J.; Minore, A.; Goumas, I.K.; Cindolo, L. Primary bladder neck obstruction in men—New perspectives in physiopathology. Prostate Cancer Prostatic Dis. 2024, 27, 54–57. [Google Scholar] [CrossRef]
- Cocci, A.; Pezzoli, M.; Lo Re, M.; Russo, G.I.; Asmundo, M.G.; Fode, M.; Cacciamani, G.; Cimino, S.; Minervini, A.; Durukan, E. Quality of information and appropriateness of ChatGPT outputs for urology patients. Prostate Cancer Prostatic Dis. 2024, 27, 159–160. [Google Scholar] [CrossRef]
- Cicione, A.; Lombardo, R.; Nacchia, A.; Turchi, B.; Gallo, G.; Zammitti, F.; Ghezzo, N.; Guidotti, A.; Franco, A.; Rovesti, L.M.; et al. Post-voided residual urine ratio as a predictor of bladder outlet obstruction in men with lower urinary tract symptoms: Development of a clinical nomogram. World J. Urol. 2023, 41, 521–527. [Google Scholar] [CrossRef] [PubMed]
- De Nunzio, C.; Lombardo, R.; Gacci, M.; Milanesi, M.; Cancrini, F.; Tema, G.; Cocci, A.; Giordano, G.; Leonardo, C.; Carini, M.; et al. The Diagnosis of Benign Prostatic Obstruction: Validation of the Young Academic Urologist Clinical Nomogram. Urology 2015, 86, 1032–1036. [Google Scholar] [CrossRef] [PubMed]
- Lombardo, R.; Gallo, G.; Stira, J.; Turchi, B.; Santoro, G.; Riolo, S.; Romagnoli, M.; Cicione, A.; Tema, G.; Pastore, A.; et al. Quality of information and appropriateness of Open AI outputs for prostate cancer. Prostate Cancer Prostatic Dis. 2024. [Google Scholar] [CrossRef]
- Suarez-Ibarrola, R.; Miernik, A. Prospects and Challenges of Artificial Intelligence and Computer Science for the Future of Urology. World J. Urol. 2020, 38, 2325–2327. [Google Scholar] [CrossRef]
- Zhang, M.; Lin, X.; Zheng, Z.; Chen, Y.; Ren, Y.; Zhang, X. Artificial intelligence models derived from 2D transperineal ultrasound images in the clinical diagnosis of stress urinary incontinence. Int. Urogynecol. J. 2022, 33, 1179–1185. [Google Scholar] [CrossRef] [PubMed]
- Hobbs, K.T.; Choe, N.; Aksenov, L.I.; Reyes, L.; Aquino, W.; Routh, J.C.; Hokanson, J.A. Machine Learning for Urodynamic Detection of Detrusor Overactivity. Urology 2022, 159, 247–254. [Google Scholar] [CrossRef] [PubMed]
- Nino, A.K.P.; Perez, V.G.; Secco, S.; De Nunzio, C.; Lombardo, R.; Tikkinen, K.A.O.; Elterman, D.S. Can ChatGPT provide high-quality patient information on male lower urinary tract symptoms suggestive of benign prostate enlargement? Prostate Cancer Prostatic Dis. 2024, 1–6. [Google Scholar] [CrossRef]
- Rubilotta, E.; Balzarro, M.; Trabacchin, N.; Righetti, R.; D’amico, A.; Blaivas, J.G.; Antonelli, A. Post-void residual urine ratio: A novel clinical approach to the post-void residual urine in the assessment of males with lower urinary tract symptoms. Investig. Clin. Urol. 2021, 62, 470–476. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Rubilotta, E.; Balzarro, M.; Gubbiotti, M.; Antonelli, A. Role of Bladder Emptying on Outcomes of Transurethral Resection of the Prostate. Urology 2023, 175, 25–28. [Google Scholar] [CrossRef] [PubMed]
- Ahyai, S.A.; Gilling, P.; Kaplan, S.A.; Kuntz, R.M.; Madersbacher, S.; Montorsi, F.; Speakman, M.J.; Stief, C.G. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur. Urol. 2010, 58, 384–397. [Google Scholar] [CrossRef]
- Hakenberg, O.W.; Pinnock, C.B.; Marshall, V.R. Does evaluation with the International Prostate Symptom Score predict the outcome of transurethral resection of the prostate? J. Urol. 1997, 158, 94–99. [Google Scholar] [CrossRef]
- De Nunzio, C.; Lombardo, R.; Nacchia, A.; Deroma, M.; Alkhatatbeh, H.; Brassetti, A.; Tubaro, A. Young Academic Urologists’ benign prostatic obstruction nomogram predicts clinical outcome in patients treated with transurethral resection of prostate: An Italian cohort study. Minerva Urol. Nefrol. 2018, 70, 211–217. [Google Scholar] [CrossRef]
- Busetto, G.M.; Lombardo, R.; De Nunzio, C.; Santoro, G.; Tocci, E.; Schiavone, N.; Tubaro, A.; Carrieri, G.; Kaplan, S.A.; Herrmann, T.R.W. Ejaculation sparing of classic and minimally invasive surgical treatments of LUTS/BPH. Prostate Cancer Prostatic Dis. 2024; epub ahead of print. [Google Scholar] [CrossRef] [PubMed]
- Gravas, S.; De Nunzio, C.; Campos Pinheiro, L.; Ponce de León, J.; Skriapas, K.; Milad, Z.; Lombardo, R.; Medeiros, M.; Makrides, P.; Samarinas, M.; et al. Development and validation of a clinical nomogram to predict prostatic inflammation in men with lower urinary tract symptoms. Prostate Cancer Prostatic Dis. 2024; epub ahead of print. [Google Scholar] [CrossRef] [PubMed]
- De Nunzio, C.; Lombardo, R.; Cicione, A.; Trucchi, A.; Carter, S.; Tema, G.; Nacchia, A.; Vicentini, C.; Tubaro, A. The role of bladder wall thickness in the evaluation of detrusor underactivity: Development of a clinical nomogram. Neurourol. Urodyn. 2020, 39, 1115–1123. [Google Scholar] [CrossRef] [PubMed]
- Eure, G.; Rukstalis, D.; Roehrborn, C. Prostatic Urethral Lift for Obstructive Median Lobes: Consistent Results Across Controlled Trial and Real-World Settings. J. Endourol. 2023, 37, 50–59. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
Baseline | |
---|---|
Age (years) | 63 (56–69) |
BMI (kg/m2) | 26 (24–28) |
Hypertension | 10/20 (50%) |
Diabetes | 2/20 (10%) |
Alpha-blockers treatment | 16/20 (80%) |
5-ARI treatment | 6/20 (30%) |
Antimuscarinic treatment | 1/20 (5%) |
Prostate Volume (cc) | 43 (38–50) |
PSA (ng/mL) | 2.8 (1.5–3.8) |
vIPSS | 10 (7–13) |
sIPSS | 6.5 (4–8) |
IPSS | 16 (13–23) |
MSHQ | 10 (3–13) |
IIEF | 23(21–25) |
Free flow Qmax (mL/s) | 8.5 (7–11) |
Baseline | 6 Months | p | |
---|---|---|---|
vIPSS | 9.5 (7–13) | 5 (3–6) | 0.001 |
sIPSS | 6.5 (4–8) | 4 (3–6) | 0.001 |
IPSS | 16 (13–23) | 10.5 (7–12) | 0.001 |
Free flow Qmax | 8.5 (7–11) | 11.5 (10–15.5) | 0.001 |
IIEF | 23 (21–25) | 22 (21–25) | 0.255 |
MSHQ | 10 (3–13) | 12.5 (6–14) | 0.001 |
Baseline | 6 Months | p | |
---|---|---|---|
UDN-Qmax (mL/s) | 8 (5–10) | 11 (8–13) | 0.001 |
pdetQmax (cmH20) | 55 (48–66) | 49 (32–61) | 0.231 |
BCI | 95 (78–110) | 100 (88–127) | 0.001 |
BOOI | 39 (29–54) | 18 (11–38) | 0.001 |
Schäfer Class | III (II–IV) | II (I–II) | 0.006 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lombardo, R.; Santarelli, V.; Turchi, B.; Santoro, G.; Guercio, A.; Franco, A.; Secco, S.; Dell’Oglio, P.; Galfano, A.; Olivero, A.; et al. Evaluation of Peri-Operative Outcomes after Prostatic Urethral Lift with Emphasis on Urodynamic Changes, Symptom Improvement and Sexual Function. Diagnostics 2024, 14, 2110. https://doi.org/10.3390/diagnostics14192110
Lombardo R, Santarelli V, Turchi B, Santoro G, Guercio A, Franco A, Secco S, Dell’Oglio P, Galfano A, Olivero A, et al. Evaluation of Peri-Operative Outcomes after Prostatic Urethral Lift with Emphasis on Urodynamic Changes, Symptom Improvement and Sexual Function. Diagnostics. 2024; 14(19):2110. https://doi.org/10.3390/diagnostics14192110
Chicago/Turabian StyleLombardo, Riccardo, Valerio Santarelli, Beatrice Turchi, Giuseppe Santoro, Alessandro Guercio, Antonio Franco, Silvia Secco, Paolo Dell’Oglio, Antonio Galfano, Alberto Olivero, and et al. 2024. "Evaluation of Peri-Operative Outcomes after Prostatic Urethral Lift with Emphasis on Urodynamic Changes, Symptom Improvement and Sexual Function" Diagnostics 14, no. 19: 2110. https://doi.org/10.3390/diagnostics14192110